Heart Problems Linked To Breast Cancer Drug

Earlier this summer, I warned you about the one of the more insidious marketing strategies the mega-drug companies trot out from time-to-time -- the element of fear -- to trick people into using their toxic products, especially those marketed to breast cancer patients. What happens when the toxic side effects of taking a drug far outweigh any good it does?

Apparently, that's the case with Herceptin, a drug sold by Genentech to treat breast cancer. The early review of Herceptin: Breast cancer patients run a much higher risk of heart problems, compared to those who received chemotherapy alone.

Based on a three-year study of more than 2,000 patients, the rate of congestive heart failure and cardiac death among those who took Herceptin was 4.1 percent compared to those who opted for chemotherapy (0.8 percent).

Fact is, folks, most people -- not the mega-drug companies -- are confused about the real cause of cancer and all disease. In no way, shape or form is it related to a drug deficiency or some random event that is waiting in the wings to strike us down. The vast majority of the time, it is completely related to circumstances that we can control.

I've devoted plenty of pages on my Web site to show you how to reduce your cancer risks almost completely. Here's some of my major recommendations:

MSNBC August 31, 2005

Post your comment
Click Here and be the first to comment on this article